SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
United States Cellular Corporation (USM) trades at a trailing P/E of 39.3, forward P/E of 70.0. Trailing earnings yield is 2.55%, forward earnings yield 1.43%.
Criteria proven by this page:
- VALUE (46/100, Partial) — mixed signals — some valuation metrics are favorable while others are stretched.
- Trailing Earnings Yield 2.55% — below bond yields — investors are paying a premium for expected growth rather than current earnings.
- Analyst consensus target $80.50 (+4.5% upside) — modest upside expected.
Overall SharesGrow Score: 57/100 with 1/7 criteria passed.
SharesGrow 7-Criteria Score
~
VALUE
46/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — USM
Valuation Multiples
P/E (TTM)39.3
Forward P/E70.0
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio41.59
EV/EBITDA0.0
Per Share Data
EPS (TTM)$1.96
Forward EPS (Est.)$1.10
Book Value / Share$0.00
Revenue / Share$1.85
FCF / Share$0.00
Yields & Fair Value
Earnings Yield2.55%
Forward Earnings Yield1.43%
Dividend Yield0.00%
Analyst Target$80.50 (+4.5%)
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$0.56 |
$3.94B |
$48M |
1.2% |
| 2017 |
$0.14 |
$3.89B |
$12M |
0.3% |
| 2018 |
$1.72 |
$3.97B |
$150M |
3.8% |
| 2019 |
$1.44 |
$4.02B |
$127M |
3.2% |
| 2020 |
$2.63 |
$4.04B |
$229M |
5.7% |
| 2021 |
$1.78 |
$4.12B |
$155M |
3.8% |
| 2022 |
$0.35 |
$4.17B |
$30M |
0.7% |
| 2023 |
$0.62 |
$3.91B |
$54M |
1.4% |
| 2024 |
$-0.45 |
$3.77B |
$-39M |
-1% |
| 2025 |
$1.96 |
$162.96M |
$172.27M |
105.7% |
